1. Home
  2. AISP vs CGTX Comparison

AISP vs CGTX Comparison

Compare AISP & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airship AI Holdings Inc.

AISP

Airship AI Holdings Inc.

HOLD

Current Price

$2.03

Market Cap

66.8M

Sector

Finance

ML Signal

HOLD

CGTX

Cognition Therapeutics Inc.

BUY

Current Price

$0.73

Market Cap

79.6M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
AISP
CGTX
Founded
2006
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.8M
79.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
AISP
CGTX
Price
$2.03
$0.73
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $3.33
AVG Volume (30 Days)
★ 2.6M
470.3K
Earning Date
11-16-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 132.48
62.79
EPS
N/A
N/A
Revenue
★ $15,321,349.00
N/A
Revenue This Year
$78.84
N/A
Revenue Next Year
$47.81
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.69
$0.55
52 Week High
$5.35
$1.93

Technical Indicators

Market Signals
Indicator
AISP
CGTX
Relative Strength Index (RSI) 46.66 22.27
Support Level $1.95 $0.55
Resistance Level $2.12 $1.18
Average True Range (ATR) 0.23 0.06
MACD -0.00 -0.02
Stochastic Oscillator 20.28 4.23

Price Performance

Historical Comparison
AISP
CGTX

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture. Airship AI's software allows customers to view structured data both in real-time as well as to conduct searches on the structured data at a later point in time.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).

Share on Social Networks: